Results 201 to 210 of about 17,612,218 (346)

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Risk of relapse: TB treatment outcome associates with differentially culturable <i>M. tuberculosis</i> counts in sputum samples. [PDF]

IJTLD Open
Decker J, Mukamolova GV, Garton N, Grint DJ, Barer MR.   +4 more
europepmc   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome. [PDF]

Kidney Int Rep
van den Berge BT, Jansen J, Wetzels JFM, Smeets B, Maas RJ.   +4 more
europepmc   +1 more source

Impact of new treatments for respiratory failure on outcome of infants with congenital diaphragmatic hernia [PDF]

, 1999
Marco Somaschini, G. Locatelli, L. Salvoni, Cristina Bellan, Riccardo Colombo   +4 more
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study. [PDF]

Lancet Reg Health Am
Ferreira IBB, Menezes RC, Araújo-Pereira M, Rolla VC, Kritski AL, Cordeiro-Santos M, Sterling TR, Staats C, Amorim G, Trajman A, Andrade BB, RePORT-Brazil Consortium.   +11 more
europepmc   +1 more source

Single-Subject Anxiety Treatment Outcome Prediction using Functional Neuroimaging

Neuropsychopharmacology, 2014
T. Ball, M. Stein, H. Ramsawh, L. Campbell-Sills, M. Paulus   +4 more
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Clinical and radiological profile of tuberculosis and treatment outcome in patients ≤18 years: A prospective study. [PDF]

J Family Med Prim Care
Madhuri K, Subhankar S, Mohapatra AK, Jagaty SK, Behera D, Das A, Parida S, Mishra S.   +7 more
europepmc   +1 more source